PLATINUM INVESTMENT MANAGEMENT LTD - ORCHARD THERAPEUTICS PLC ownership

ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 63 filers reported holding ORCHARD THERAPEUTICS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PLATINUM INVESTMENT MANAGEMENT LTD ownership history of ORCHARD THERAPEUTICS PLC
ValueSharesWeighting
Q4 2021$1,762,000
-29.0%
1,335,174
+23.8%
0.05%
-30.0%
Q3 2021$2,480,000
-24.9%
1,078,315
+43.4%
0.07%
-7.9%
Q2 2021$3,302,000
-27.3%
752,108
+20.2%
0.08%
-24.8%
Q1 2021$4,545,000
+55.7%
625,969
-7.4%
0.10%
+50.7%
Q4 2020$2,920,000
+72.5%
675,969
+64.1%
0.07%
+59.5%
Q3 2020$1,693,000
-21.0%
411,977
+15.4%
0.04%
-14.3%
Q2 2020$2,142,000
+105.0%
357,020
+157.2%
0.05%
+88.5%
Q1 2020$1,045,000138,8270.03%
Other shareholders
ORCHARD THERAPEUTICS PLC shareholders Q1 2022
NameSharesValueWeighting ↓
CHI Advisors LLC 5,307,751$3,101,0001.18%
TANG CAPITAL MANAGEMENT LLC 2,000,000$1,168,0000.18%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,949,416$4,060,0000.08%
Artal Group S.A. 1,803,858$1,054,0000.06%
GSA CAPITAL PARTNERS LLP 616,402$360,0000.05%
RA Capital Management 3,040,885$1,776,0000.05%
Forefront Analytics, LLC 92,641$58,0000.03%
Temasek Holdings (Private) Ltd 4,319,049$2,523,1880.01%
FEDERATED HERMES, INC. 8,309,859$4,853,0000.01%
Cormorant Asset Management, LP 256,649$150,0000.01%
View complete list of ORCHARD THERAPEUTICS PLC shareholders